Clinical Trial Update: Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing induction Gemcitabine and Cisplatin versus Gemcitabine, Cisplatin, Pembrolizumab, and Bevacizumab in nasopharyngeal cancer is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Cisplatin (Platinol) (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: RECRUITING